Optimization of Phloretin-loaded Nanospanlastics for Targeting of FAS/SREBP1c/AMPK/ OB-Rb Signaling Pathway in HFD-induced Obesity.

MLA

Alamir, Mohamed, et al. “Optimization of Phloretin-Loaded Nanospanlastics for Targeting of FAS/SREBP1c/AMPK/ OB-Rb Signaling Pathway in HFD-Induced Obesity.” Current Pharmaceutical Biotechnology, vol. 26, no. 1, 2024, pp. 92–107. EBSCOhost, https://doi.org/10.2174/0113892010278684240105115516.

APA

Alamir, M., Hussein, M. A., Aboud, H. M., Khedr, M. H., & Zanaty, M. I. (2024). Optimization of Phloretin-loaded Nanospanlastics for Targeting of FAS/SREBP1c/AMPK/ OB-Rb Signaling Pathway in HFD-induced Obesity. Current Pharmaceutical Biotechnology, 26(1), 92–107. https://doi.org/10.2174/0113892010278684240105115516

Chicago

Alamir, Mohamed, Mohamed A Hussein, Heba M Aboud, Mohamed H Khedr, and Mohamed I Zanaty. 2024. “Optimization of Phloretin-Loaded Nanospanlastics for Targeting of FAS/SREBP1c/AMPK/ OB-Rb Signaling Pathway in HFD-Induced Obesity.” Current Pharmaceutical Biotechnology 26 (1): 92–107. doi:10.2174/0113892010278684240105115516.